[持续输注兰地洛尔对全身麻醉苏醒期新斯的明-阿托品给药后心率变化的影响]
[The effects of continuous infusion of landiolol on heart rate changes after neostigmine-atropine administration during recovery from general anesthesia].
作者信息
Nonaka Akihiko, Suzuki Satomi, Abe Fumiaki
机构信息
Department of Anesthesia, Yamanashi Prefectural Central Hospital, Yamanashi.
出版信息
Masui. 2006 Dec;55(12):1459-62.
BACKGROUND
On reversal of muscle relaxants when neostigmine-atropine mixture is used, heart rate changes occurr. We examined whether landiolol attenuate the initial increases in heart rate after intravenous injections of a neostigmine-atropine mixture.
METHODS
Twenty-four patients were assigned to one of two groups (n=12 each): control group and landiolol group. Anesthesia was induced with propofol and was maintained with isoflurane-nitrous oxide-pentazocine. A mixture of neostigmine 2 mg and atropine 1 mg was injected intravenously over 30s in the control group. In the landiolol group, 0.125 mg x kg)-1) x min(-1) of landiolol for 1 minute was administered immediately after neostigmine-atropine injection. Blood pressure and heart rate were measured noninvasively.
RESULTS
Heart rate was significantly increased after neostigmine-atropine administration compared with that at pre-administration in both groups. At 2 and 3 minutes after neostigmine-atropine administration, heart rate in the landiolol group was significantly lower than that in the control group. The maximum increase in heart rate after the neostigmine-atropine injections was significantly less in the landiolol group than that in the control group. Blood pressure showed no significant changes in both groups during the observation period.
CONCLUSIONS
Landiolol was useful for heart rate control after neostigmine-atropine administration during recovery from general anesthesia.
背景
使用新斯的明 - 阿托品合剂逆转肌肉松弛剂时,会出现心率变化。我们研究了兰地洛尔是否能减轻静脉注射新斯的明 - 阿托品合剂后最初的心率升高。
方法
24例患者被分为两组(每组n = 12):对照组和兰地洛尔组。麻醉诱导采用丙泊酚,维持采用异氟烷 - 氧化亚氮 - 喷他佐辛。对照组在30秒内静脉注射2毫克新斯的明和1毫克阿托品的合剂。在兰地洛尔组,新斯的明 - 阿托品注射后立即给予0.125毫克/(千克·分钟)的兰地洛尔,持续1分钟。无创测量血压和心率。
结果
两组新斯的明 - 阿托品给药后心率均较给药前显著升高。新斯的明 - 阿托品给药后2分钟和3分钟时,兰地洛尔组心率显著低于对照组。新斯的明 - 阿托品注射后心率的最大升高值在兰地洛尔组显著低于对照组。观察期间两组血压均无显著变化。
结论
在全身麻醉恢复过程中,兰地洛尔有助于控制新斯的明 - 阿托品给药后的心率。